4-Methoxybenzoic acid

CAS No. 100-09-4

4-Methoxybenzoic acid( p-Anisic acid | NSC 32742 )

Catalog No. M17742 CAS No. 100-09-4

4-Methoxybenzoic acid could be used as raw material in cosmetic and dermatologic products and/or aroma components in foodstuffs, it has antiinflammatory and antimicrobial activities.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
100MG 41 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    4-Methoxybenzoic acid
  • Note
    Research use only, not for human use.
  • Brief Description
    4-Methoxybenzoic acid could be used as raw material in cosmetic and dermatologic products and/or aroma components in foodstuffs, it has antiinflammatory and antimicrobial activities.
  • Description
    p-Anisic acid, also known as 4-methoxybenzoic acid or draconic acid, is one of the isomers of anisic acid. The term "anisic acid" often refers to this form specifically. p-Anisic acid is found naturally in anise.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    p-Anisic acid | NSC 32742
  • Pathway
    Angiogenesis
  • Target
    CDK
  • Recptor
    antibacterial
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    100-09-4
  • Formula Weight
    152.14
  • Molecular Formula
    C8H8O3
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 100 mg/mL (657.25 mM)
  • SMILES
    COC1=CC=C(C=C1)C(=O)O
  • Chemical Name
    Benzoic acid, 4-methoxy-

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Cortistatin A

    A potent and selective inhibitor of mediator-associated kinase CDK8 (IC50=12 nM) and its paralogue CDK19.

  • Eciruciclib

    Eciruciclib is an inhibitor of CDK with antitumor properties.

  • LY2835219 mesylate

    LY2835219 is a potent and selective inhibitor of CDK4 and CDK6 with IC50 of 2 nM and 10 nM in cell-free assays, respectively. Phase 3.